Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

A 25-year-old woman reporting an allergy to penicillin

Lucas R. Castellani, Wayne L. Gold and Derek R. MacFadden
CMAJ October 06, 2015 187 (14) 1065-1066; DOI: https://doi.org/10.1503/cmaj.141123
Lucas R. Castellani
Department of Medicine (Castellani, Gold, MacFadden), University of Toronto, Toronto, Ont.; Division of Infectious Diseases (Gold, MacFadden), University Health Network, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne L. Gold
Department of Medicine (Castellani, Gold, MacFadden), University of Toronto, Toronto, Ont.; Division of Infectious Diseases (Gold, MacFadden), University Health Network, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek R. MacFadden
Department of Medicine (Castellani, Gold, MacFadden), University of Toronto, Toronto, Ont.; Division of Infectious Diseases (Gold, MacFadden), University Health Network, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: derek.macfadden@mail.utoronto.ca
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

During routine antenatal screening of a 25-year-old woman in her first trimester of pregnancy, positive results are obtained on serologic testing for syphilis, and after investigation, late latent syphilis is diagnosed. Standard treatment for this stage of syphilis in pregnancy consists of three weekly intramuscular injections of penicillin G benzathine.1 The patient reports that her mother told her she had an allergic reaction to penicillin as a child, the details of which neither can recall.

On the basis of her history, is this patient likely to have an allergy to penicillin?

Allergy to penicillin is self-reported by about 10% of the general population, but only 10% of those reporting an allergy have a positive result on penicillin skin testing.2,3 When assessing a patient with reported penicillin allergy, the clinician must obtain a detailed history. Important questions to be asked are listed in Box 1. Commonly, as in this patient, the history of allergic reactions is remote and difficult to recall.2

Box 1: Questions to ask when eliciting a history of IgE-mediated penicillin allergy2–4
QuestionsRationale
Age: How long ago did the patient’s reported allergic reaction to penicillin occur? How old was the patient at the time of the reported allergic reaction?The longer the time elapsed since the reaction, the lower the likelihood that the patient will experience an IgE-mediated reaction, as patients can outgrow hypersensitivity reactions with time. If the patient was very young at the time of the reaction, he or she may have learned of it through information relayed by family members, which increases the risk of historical inaccuracies.
Administration of penicillin: How was the penicillin administered?The parenteral and cutaneous routes are thought to confer greater risk of sensitization than oral administration.
Symptoms: Did the reaction include hives, throat swelling, diarrhea, vomiting or shortness of breath? Were other organ systems involved? If the only symptom was a rash, what was its distribution and pattern?It is important to differentiate symptoms reflecting a true IgE-mediated allergy from less serious or sometimes more severe (e.g., Stevens–Johnson syndrome) non–IgE-mediated reactions. If the reaction consisted solely of a rash, non–IgE-mediated causes should be carefully considered.
Timing: How long after the penicillin was administered did the onset of symptoms occur?It is important to identify the temporal relationship between drug administration and onset of the reaction. Most IgE-mediated reactions occur immediately (within one hour), whereas substantial delays between administration and reaction suggest a non–IgE-mediated drug reaction or another alternative cause for the symptoms.
Other medications: Was the patient taking other medications when the penicillin was administered? If so, what were they, and when were they taken in relation to the reaction?Penicillins are often given in conjunction with other medications, and it may be one of the other medications that is the real precipitant of the reported reaction.
Previous reactions: Has the patient had previous reactions to other medications?Some patients may have documented reactions to related drugs (e.g., cephalosporins, carbapenems), which may indicate that they are at risk of a severe reaction if penicillin is administered.
Exposure to β-lactam antibiotics: Has penicillin or any other β-lactam antibiotic been safely administered to the patient either before or after the reported reaction to penicillin?Subsequent exposure to penicillin without a reaction suggests that the patient does not have an IgE-mediated allergy. It is also important to determine whether other β-lactam antibiotics have been safely administered.
  • Note: IgE = immunoglobulin E.

Features of hypersensitivity reactions mediated by immunoglobulin E (IgE) (i.e., type 1 reactions) include urticaria, angioedema, gastrointestinal symptoms and bronchospasm. These reactions usually occur within one hour of exposure and can lead to anaphylaxis. Some IgE-mediated reactions may occur 1–72 hours after administration.2 Delayed (non–IgE-mediated) reactions occur hours to days after exposure.3

How can a type 1 allergic reaction to penicillin be excluded in this patient?

When a clear history cannot be elicited, skin testing is currently the method of choice for excluding type 1 reactions to penicillin.3,4 This most often requires the help of an expert in allergy.3 Penicillin skin testing consists of prick testing followed by intradermal instillation of small quantities of major (penicilloyl–polylysine) and minor (penicillin G, penicilloate and penilloate) determinants and observation for a wheal.3

A negative result on skin testing with both major and minor determinants has a negative predictive value for an immediate hypersensitivity reaction nearing 100%.3 For safety reasons, a negative skin test result is typically followed by a graded challenge, which involves administration of several incremental, subtherapeutic doses of penicillin.3,4 For patients who tolerate this graded challenge, penicillin can be prescribed.3 Skin testing or graded challenges should not be performed in patients with a history suggestive of severe delayed hypersensitivity reactions such as Stevens–Johnson syndrome.3 Skin testing can be safely performed in pregnancy.5,6

If this patient has a positive result on skin testing for penicillin allergy, can she still be treated safely with penicillin?

The positive predictive value of a penicillin skin test ranges from 40% to 100%.3 Therefore, if a patient has a positive skin test result, penicillin can still be administered through a carefully observed desensitization process, which would be performed by an allergy expert.3,4 Desensitization involves administering incremental doses of the drug in a monitored setting until the therapeutic dose is achieved. The purpose of desensitization is to induce tolerance without triggering adverse effects, and this is maintained only if the drug is administered continually.4 Desensitization can be safely performed in pregnancy.5,6

If this patient has a positive result on skin testing, can she be treated with other β-lactam antibiotics in the future?

It was previously believed that individuals with penicillin allergy had a 10% risk of immediate hypersensitivity with the administration of cephalosporins. However, this belief was based on studies in which the cephalosporin administered contained trace amounts of penicillin.3,4 Currently, it is believed that the rate of cross-reactivity is closer to 1%.3 Data suggest that characteristics of the side chains, and not the β-lactam ring itself, are most responsible for cross-reactivity between various β-lactam antibiotics.3,4 Patients with a prior history suggestive of IgE-mediated penicillin allergy have only a 2% risk of IgE-mediated reaction to carbapenems.7 Aztreonam does not cross-react with other β-lactam agents except for ceftazidime.3 If a patient has a positive result on penicillin skin testing and treatment with a cephalosporin or carbapenem is indicated, he or she can undergo a graded challenge.3

The case revisited

The patient was referred to an allergist for penicillin skin testing, the result of which was negative. This was followed by a graded challenge, which was tolerated. The patient was subsequently treated with intramuscular penicillin G benzathine for her late latent syphilis, without adverse event. Her allergy history was updated in her clinic records to indicate that she did not have an allergy to penicillin.

Acknowledgement

The authors would like to thank Dr. Neil Shear for his critical (presubmission) review of the manuscript.

Footnotes

  • Competing interests: None declared

  • This article has been peer reviewed.

  • Contributors: Wayne Gold and Derek MacFadden were responsible for the concept for this article. All authors contributed to the literature review. Lucas Castellani was responsible for writing the initial draft of the manuscript. All authors contributed to revising the manuscript, responding to reviewers and approving the final version for publication, and all agree to be guarantors for the work.

References

  1. ↵
    Canadian guidelines on sexually transmitted infections. Ottawa: Public Health Agency of Canada; [updated continually]. Available: www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/index-eng.php (accessed 30 Aug. 2014).
  2. ↵
    1. Salkind AR,
    2. Cuddy PG,
    3. Foxworth JW
    . Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001;285:2498–505.
    OpenUrlCrossRefPubMed
  3. ↵
    Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010;105:259–73.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Legendre DP,
    2. Muzny CA,
    3. Marshall GD,
    4. et al
    . Antibiotic hypersensitivity reactions and approaches to desensitization. Clin Infect Dis 2014;58:1140–8.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Macy E
    . Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization. Ann Allergy Asthma Immunol 2006;97:164–8.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Wendel GD,
    2. Stark BJ,
    3. Jamison RB,
    4. et al
    . Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985;312:1229–32.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Kula B,
    2. Djordjevic G,
    3. Robinson J
    . A systematic review: Can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins? Clin Infect Dis 2014;59:1113–22. Erratum in: Clin Infect Dis. 2015;60:175.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 187 (14)
CMAJ
Vol. 187, Issue 14
6 Oct 2015
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A 25-year-old woman reporting an allergy to penicillin
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A 25-year-old woman reporting an allergy to penicillin
Lucas R. Castellani, Wayne L. Gold, Derek R. MacFadden
CMAJ Oct 2015, 187 (14) 1065-1066; DOI: 10.1503/cmaj.141123

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
A 25-year-old woman reporting an allergy to penicillin
Lucas R. Castellani, Wayne L. Gold, Derek R. MacFadden
CMAJ Oct 2015, 187 (14) 1065-1066; DOI: 10.1503/cmaj.141123
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • On the basis of her history, is this patient likely to have an allergy to penicillin?
    • How can a type 1 allergic reaction to penicillin be excluded in this patient?
    • If this patient has a positive result on skin testing for penicillin allergy, can she still be treated safely with penicillin?
    • If this patient has a positive result on skin testing, can she be treated with other β-lactam antibiotics in the future?
    • The case revisited
    • Acknowledgement
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Pneumopericardium as a complication of pericardiocentesis
  • A blistering variant of phlegmasia cerulea dolens from underlying squamous cell lung cancer
  • Parechovirus infections in infants
Show more Practice

Decisions

  • A 38-year-old man who uses crack cocaine
  • A 35-year-old man with a positive Lyme test result from a private laboratory
Show more Decisions

Similar Articles

Collections

  • Article Types
    • Decisions
  • Topics
    • Allergy
    • Drugs: adverse reactions
    • Drugs: antimicrobials
    • Reproductive health, infertility & pregnancy
    • Sexually transmitted infections

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire